Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Clinical trial NCT00374322 · COMPLETED

Trial details

NCT number: NCT00374322
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2006-08-01
Primary completion: 2011-09-01
Enrollment: 3166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.